A vital sign-based prediction algorithm for differentiating COVID-19 versus seasonal influenza in hospitalized patients.
Naveena YanamalaNanda H KrishnaQuincy A HathawayAditya RadhakrishnanSrinidhi SunkaraHeenaben PatelPeter FarjoBrijesh PatelPartho P SenguptaPublished in: NPJ digital medicine (2021)
Patients with influenza and SARS-CoV2/Coronavirus disease 2019 (COVID-19) infections have a different clinical course and outcomes. We developed and validated a supervised machine learning pipeline to distinguish the two viral infections using the available vital signs and demographic dataset from the first hospital/emergency room encounters of 3883 patients who had confirmed diagnoses of influenza A/B, COVID-19 or negative laboratory test results. The models were able to achieve an area under the receiver operating characteristic curve (ROC AUC) of at least 97% using our multiclass classifier. The predictive models were externally validated on 15,697 encounters in 3125 patients available on TrinetX database that contains patient-level data from different healthcare organizations. The influenza vs COVID-19-positive model had an AUC of 98.8%, and 92.8% on the internal and external test sets, respectively. Our study illustrates the potentials of machine-learning models for accurately distinguishing the two viral infections. The code is made available at https://github.com/ynaveena/COVID-19-vs-Influenza and may have utility as a frontline diagnostic tool to aid healthcare workers in triaging patients once the two viral infections start cocirculating in the communities.
Keyphrases
- sars cov
- coronavirus disease
- machine learning
- respiratory syndrome coronavirus
- healthcare
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- public health
- big data
- peritoneal dialysis
- prognostic factors
- artificial intelligence
- deep learning
- emergency department
- type diabetes
- magnetic resonance
- adipose tissue
- magnetic resonance imaging
- adverse drug
- emergency medical